Table 5 Lyophilized biologic effects on blood biochemistry (mean ± SD).
Dosage | Time | TG (mmol/L) | UREA (mmol/L) | ALT (U/L) | AST (U/L) | TP (g/L) | ALB (g/L) |
|---|---|---|---|---|---|---|---|
5-fold | Pre-dose | 0.31 ± 0.01a | 9.62 ± 0.53b | 24.15 ± 4.25c | 115.90 ± 24.80d | 54.45 ± 0.45e | 26.25 ± 0.55f |
15 d | 0.36 ± 0.09a | 10.09 ± 0.27b | 19.60 ± 3.00c | 98.40 ± 17.00d | 53.05 ± 5.65e | 28.35 ± 1.55f | |
30 d | 0.44 ± 0.00a | 9.79 ± 0.14b | 19.20 ± 7.10c | 94.60 ± 39.40d | 44.90 ± 13.40e | 27.75 ± 2.35f | |
10-fold | Pre-dose | 0.43 ± 0.04a | 9.28 ± 0.92b | 17.95 ± 1.45c | 93.40 ± 5.80d | 53.00 ± 2.90e | 25.75 ± 0.85f |
15 d | 0.34 ± 0.05a | 9.98 ± 0.15b | 16.25 ± 1.75c | 79.05 ± 25.55d | 48.35 ± 12.75e | 24.60 ± 3.90f | |
30 d | 0.44 ± 0.03a | 8.8 ± 1.18b | 16.70 ± 5.30c | 78.80 ± 32.00d | 40.45 ± 11.05e | 24.75 ± 1.05f | |
Control | Pre-dose | 0.31 ± 0.06a | 8.91 ± 0.17b | 20.05 ± 0.65c | 99.95 ± 0.95d | 46.85 ± 12.23e | 28.95 ± 4.15f |
15 d | 0.30 ± 0.05a | 10.16 ± 0.18b | 20.30 ± 0.80c | 120.10 ± 18.90d | 53.60 ± 2.00e | 26.60 ± 0.90f | |
30 d | 0.33 ± 0.00a | 8.63 ± 0.49b | 16.15 ± 0.75c | 94.15 ± 1.15d | 46.90 ± 0.80e | 27.05 ± 2.05f |